SCHEMBL17348455

SCHEMBL17348455

CC1=C(C)c2c(ccc3ccccc23)CN1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.42
NISCH Q9Y2I1 2/20 0.40
CYP2A6 P11509 4/20 0.37
TSHR P16473 3/20 0.37
CYP1A2 P05177 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
HPRT1 P00492 1/20 0.34
RAB9A P51151 2/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
ATM Q13315 1/20 0.34
HIF1A Q16665 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HTR1A P08908 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31069613 0.75 AURKA (0.47) CYP2A6TSHRALDH1A1HSD17B10TDP1
SCHEMBL4298702 0.74 HSD17B10 (0.46) MAPTNISCHCYP2A6TSHRCYP1A2
SCHEMBL28089496 0.72 DNMT1 (0.40) MAPTNISCHCYP2A6TSHRALDH1A1
SCHEMBL17344803 0.71 MAPT (0.34) MAPTNISCHCYP2A6TSHRCYP1A2
SCHEMBL25286955 0.70 MAPT (0.39) MAPTCYP2A6TSHRCYP1A2ALDH1A1
SCHEMBL4421747 0.70 ALDH1A1 (0.46) NISCHCYP2A6TSHRCYP1A2ALDH1A1
SCHEMBL14982011 0.67 ALDH1A1 (0.38) MAPTNISCHCYP2A6TSHRCYP1A2
SCHEMBL868639 0.66 TSHR (0.52) MAPTCYP2A6TSHRCYP1A2ALDH1A1
SCHEMBL29716676 0.66 TSHR (0.52) MAPTCYP2A6TSHRCYP1A2ALDH1A1
SCHEMBL21508269 0.66 CA12 (0.52) HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2952503-B1 CARBOXYLIC ACID DERIVATIVES AS HIV REPLICATION INHIBITOR SHIONOGI & CO (JP) 2019-10-23 EP disclosed
US-20150361093-A1 HIV REPLICATION INHIBITOR SHIONOGI & CO., LTD. (JP) 2015-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361093-A1 HIV REPLICATION INHIBITOR RTF2, REV1, PCNA MAPT 3234/4885NISCH 3284/4885CYP2A6 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.